Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.

Autor: Vale CL; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK. Electronic address: claire.vale@ucl.ac.uk., Fisher DJ; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Godolphin PJ; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Rydzewska LH; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Boher JM; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France., Burdett S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Chen YH; Department of Biostatistics and Computational Biology ECOG-ACRIN Cancer Research Group, Dana-Farber Cancer Institute, Boston, MA, USA., Clarke NW; Department of Surgery and Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK., Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, Paris, France., Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., James ND; Institute of Cancer Research, London, UK., Liu G; Department of Urology, Department of Medicine, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Matheson D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Murphy L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Oldroyd RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Rogozinska E; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France., Sweeney CJ; SAiGENCI, University of Adelaide, Adelaide, SA, Australia., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Tombal B; Institut de Recherche Clinique, Université Catholique de Louvain, Louvain-la-Neuve, Belgium., White IR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Tierney JF; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Jul; Vol. 24 (7), pp. 783-797.

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.

Autor: Burdett S; Meta-analysis Group, MRC Clinical Trials Unit at UCL, London, UK. Electronic address: sarah.burdett@ucl.ac.uk., Boevé LM; Department of Urology, OLVG, Amsterdam, The Netherlands; Department of Urology, Amsterdam UMC (VU), Amsterdam, The Netherlands., Ingleby FC; MRC Clinical Trials Unit at UCL, London, UK., Fisher DJ; Meta-analysis Group, MRC Clinical Trials Unit at UCL, London, UK., Rydzewska LH; Meta-analysis Group, MRC Clinical Trials Unit at UCL, London, UK., Vale CL; Meta-analysis Group, MRC Clinical Trials Unit at UCL, London, UK., van Andel G; Department of Urology, Amsterdam UMC (VU), Amsterdam, The Netherlands., Clarke NW; The Christie and Salford Royal Hospitals, Manchester, UK., Hulshof MC; Department of Radiotherapy, Amsterdam UMC (AMC), Amsterdam, The Netherlands., James ND; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK., Parker CC; Royal Marsden Hospital, Sutton, Institute of Cancer Research, Sutton, UK., Parmar MK; MRC Clinical Trials Unit at UCL, London, UK., Sweeney CJ; Dana-Faber Cancer Institute, Boston, MA, USA., Sydes MR; MRC Clinical Trials Unit at UCL, London, UK., Tombal B; Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium., Verhagen PC; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands., Tierney JF; Meta-analysis Group, MRC Clinical Trials Unit at UCL, London, UK.

Publikováno v: European urology [Eur Urol] 2019 Jul; Vol. 76 (1), pp. 115-124. Date of Electronic Publication: 2019 Feb 28.

Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study.

Autor: Vale CL; MRC Clinical Trials Unit at UCL, London WC2B 6NH, UK., Rydzewska LH; MRC Clinical Trials Unit at UCL, London WC2B 6NH, UK larysa.rydzewska@ucl.ac.uk., Rovers MM; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, Netherlands., Emberson JR; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford, Oxford, UK., Gueyffier F; Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France Hospices Civils de Lyon, Service de Pharmacologie Clinique & Essais Thérapeutiques, Bron cedex, France., Stewart LA; Centre for Reviews and Dissemination, A/B Block Alcuin College, University of York, York, UK.

Publikováno v: BMJ (Clinical research ed.) [BMJ] 2015 Mar 06; Vol. 350, pp. h1088. Date of Electronic Publication: 2015 Mar 06.

Systematic review of therapeutic interventions in human prion disease.

Autor: Stewart LA; Centre MRC Clinical Trials Unit, London, UK. ls536@york.ac.uk, Rydzewska LH, Keogh GF, Knight RS

Publikováno v: Neurology [Neurology] 2008 Apr 08; Vol. 70 (15), pp. 1272-81.